ZIMISTOBART
UNII C41SJ1JYR1

Substance Identification & Data

This profile provides standardized clinical and technical data for Zimistobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C41SJ1JYR1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2829290-06-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
C41SJ1JYR1
CAS Registry Number
2829290-06-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZIMISTOBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12978
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
LM-85
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zimistobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZIMISTOBART

Common Names & Synonyms

ANTI-NKG2A MAB
BMS 986315 [WHO-DD]
IMMUNOGLOBULIN G1 (235-ALANINE,236-GLUTAMIC ACID,238-ALANINE,DE-C-TERMINAL LYSINE), ANTI-(HUMAN KILLER CELL LECTIN-LIKE RECEPTOR KLRC1) (HUMAN MONOCLONAL NKG2A.9-G1.3F .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NKG2A.9-G1.3F .KAPPA.-CHAIN, DIMER

Technical Codes

BMS-986315
BMS-986315-01